A Kansas-based company is charging volunteers $1 million to take part in a reverse aging clinical trial. Participants would have to travel to Cartagena, Colombia, to help the company avoid the cost of clinical trials in the United States.
According to the company, the one-off gene therapy treatment should attack the problem at the source: the telomeres.
